Physician

Andrew Spiros Dorizas, M.D.

According to 2025 Medicare claims, Andrew Dorizas, M.D. (NPI: 1336506260) practices dermatology in the Anchorage, AK market, with the plurality of this provider's patient population coming from Matanuska-Susitna, AK. This provider's primary affiliated billing organization is MEDICAL NETWORK OF ALASKA, LLC (NPI: 1033883285; TIN: 20-4985038) and primary practice location at 99654-7255. Dorizas is affiliated with the Pearl Care 1, LLC (ACO ID: A5557), participating under the MSSP model.

Dorizas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 812 traditional Medicare patients, billed 3,231 HCPCS/CPT codes, and received $271,268 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,154 prescription claims across 409 beneficiaries totaling $946,093 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 426 records totaling $229,272. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $45,257 to $271,268. Similarly, Part D prescription costs have risen steadily, from $1,382 to $946,093. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$136K$271K2020 Medicare payment: $45,257 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $169,531 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $71,471 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $97,979 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $271,268 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020162950$45,257
20214753,125$169,531
20223341,327$71,471
20233321,717$97,979
20248123,231$271,268

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$473K$946K2016 Drug cost: $1,382 (USD; Tot_Drug_Cst)2017 Drug cost: $6,378 (USD; Tot_Drug_Cst)2018 Drug cost: $140,045 (USD; Tot_Drug_Cst)2019 Drug cost: $65,345 (USD; Tot_Drug_Cst)2020 Drug cost: $27,853 (USD; Tot_Drug_Cst)2021 Drug cost: $197,785 (USD; Tot_Drug_Cst)2022 Drug cost: $172,467 (USD; Tot_Drug_Cst)2023 Drug cost: $469,087 (USD; Tot_Drug_Cst)2024 Drug cost: $946,093 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R25$1,382
20173463$6,378
201859178$140,045
20191736$65,345
2020203448$27,853
20216761,817$197,785
2022265665$172,467
2023249744$469,087
20244091,154$946,093

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more149172$104
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more258258$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more293369$73
11102Biopsy of related skin growth, first growth352385$72
17000Destruction of precancer skin growth, 1 growth175200$38

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab631,708$248,486
Dupixent SyringeDupilumab11294$39,902
KlisyriTirbanibulin11300$13,876
Clobetasol PropionateClobetasol Propionate1012,821$4,116
KetoconazoleKetoconazole2036,510$3,095

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.426$229,272Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Spiros Dorizas, M.D.?

Tedicare shows public-source Medicare data for Andrew Spiros Dorizas, M.D. (NPI 1336506260), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Spiros Dorizas, M.D. have ACO affiliation data?

Andrew Spiros Dorizas, M.D. is shown with ACO affiliation data for Pearl Care 1, LLC (MSSP, ACO ID A5557).

What billing organization is linked to Andrew Spiros Dorizas, M.D.?

Andrew Spiros Dorizas, M.D. is linked to MEDICAL NETWORK OF ALASKA, LLC (billing NPI 1033883285) in the available physician profile data.

Does Andrew Spiros Dorizas, M.D. have Open Payments data?

Andrew Spiros Dorizas, M.D. has 426 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.